MGF Dosage, Protocol, and Reconstitution Guide
MGF
MGF, or mechano growth factor, is a splice variant of IGF-1 associated with muscle repair and local recovery signaling after training or mechanical stress. It is commonly discussed for short-term repair support and satellite cell activity.
How MGF Works
Muscle Stress → Repair Signals ↑ → Muscle Cell Activity ↑ → Recovery + Growth Support
MGF is associated with the body's response to muscle stress and damage. After resistance training or injury, MGF-related signaling increases as part of the muscle repair process. Researchers are especially interested in its connection to satellite cells, which help damaged muscle tissue repair and adapt.
MGF is commonly discussed for localized muscle repair signaling after training or mechanical stress.
Native MGF is shorter-acting than PEG-MGF.
It is usually structured as a short recovery-focused protocol rather than a long weekly protocol.
Human evidence remains limited, so conservative structure and careful monitoring matter.
MGF Research Protocol
Research framework:
There is no established clinical dosing protocol for MGF. The ranges below reflect commonly discussed research and peptide-community protocols rather than an FDA-approved treatment schedule.
There is no established clinical dosing protocol for MGF. The ranges below reflect commonly discussed research and peptide-community protocols rather than an FDA-approved treatment schedule.
2 mg vial + 2.0 mL BAC Water → 1 unit = 10 mcg → Short Recovery Support
Standard Setup
Vial
2 mg
Water
2.0 mL bacteriostatic water
Concentration
1 mg/mL
Conversion
1 unit = 10 mcg
Weeks 1–2
Starting Phase
Dose100 mcg
Units10 units
Volume0.10 mL
Frequency3x weekly
Weeks 3–4
Build Phase
Dose150 mcg
Units15 units
Volume0.15 mL
Frequency3x weekly
Weeks 5–6
Peak Phase
Dose200 mcg
Units20 units
Volume0.20 mL
Frequency3x weekly
Protocol Details
Frequency2–3 times weekly
TimingCommonly post-workout or on recovery days
Cycle Length4–6 weeks
Simple structure
Native MGF is usually discussed as a short-cycle, recovery-focused peptide. Because it is shorter-acting than PEG-MGF, timing and consistency around training or recovery days are important.
Native MGF is usually discussed as a short-cycle, recovery-focused peptide. Because it is shorter-acting than PEG-MGF, timing and consistency around training or recovery days are important.
Advanced Research Protocol
Higher Research Range
Advanced
Dose200–300 mcg per injection
Important:
Because native MGF is shorter-acting, it is usually discussed as a shorter-cycle, more frequent-use peptide rather than a long-duration weekly protocol like PEG-MGF.
Because native MGF is shorter-acting, it is usually discussed as a shorter-cycle, more frequent-use peptide rather than a long-duration weekly protocol like PEG-MGF.
How to Use MGF (Timing & Injection)
Research Use StyleShort recovery-focused cycles
Research Common TimingPost-workout or recovery days
Research Common Frequency2–3x weekly
Research RouteSubcutaneous or intramuscular use is commonly discussed
When & Where to Use
Subcutaneous or intramuscular use is commonly discussed
Often used post-training
Some users prefer localized intramuscular use near trained muscle groups
Rotate injection sites consistently
Timing Notes
Post-workout timing is commonly discussed because MGF is associated with local repair signaling after mechanical stress.
Recovery-day use may be preferred when soreness or repair support is the focus.
Consistency matters more than pushing dose higher.
Reconstitution & Dosing (2 mg Vial)
Vial2 mg
Water2.0 mL
Concentration1 mg/mL
Conversion1 unit = 10 mcg
Dose Reference
10 units = 100 mcg
15 units = 150 mcg
20 units = 200 mcg
30 units = 300 mcg
Reconstitution Steps
Draw 2.0 mL bacteriostatic water
Inject slowly down vial wall
Gently swirl, do not shake
Allow powder to fully dissolve
Label with the reconstitution date
Refrigerate immediately after mixing
Storage & Shelf Life
Storage & Shelf Life
Lyophilized (Unmixed)
Lyophilized: refrigerated or frozen
Refrigerated (2–8°C): ~12–24 months
Frozen (−20°C): up to ~2–3 years
Store sealed, dry, and protected from light
Reconstituted (Mixed)
Reconstituted: refrigerate at 2–8°C
Use within ~3–4 weeks
Do not freeze after mixing
Avoid repeated temperature changes
Best Practice
Keep the vial cold, protected from light, and avoid unnecessary handling. If the solution becomes cloudy, discolored, or develops visible particles, it is safer not to continue using it.
Keep the vial cold, protected from light, and avoid unnecessary handling. If the solution becomes cloudy, discolored, or develops visible particles, it is safer not to continue using it.
Research Cycle Length & Time Between Cycles
Research Phase → Recovery + Training → Reassess → Continue or Pause
Common Research Framework
Cycle Length4–6 weeks
Longer Framework
Up to 8 weeks
Primary PhasePost-training or recovery-day support
GoalLocal muscle repair + recovery support
Research Time Between Cycles
Break4–8 weeks
Allows recovery signaling to reset
Helps assess whether soreness, performance, or local response improved
Reduces the chance of continuing without a clear training-related goal
Why the shorter framework?
MGF is generally discussed as a short-term recovery and muscle-support research peptide rather than something used continuously. There is no clinically established cycle length or required time off, so these timelines come from commonly used research and community protocols.
MGF is generally discussed as a short-term recovery and muscle-support research peptide rather than something used continuously. There is no clinically established cycle length or required time off, so these timelines come from commonly used research and community protocols.
When to Stop or Pause Early
No noticeable recovery benefit after a full cycle
Injection site irritation becomes persistent
Localized soreness or swelling worsens
You are continuing without a clear training or recovery goal
What Does the Research Show?
What We Know
MGF-related activity increases in muscle after mechanical stress and resistance exercise.
Research connects MGF signaling with muscle repair, adaptation, and satellite-cell activity.
Most synthetic MGF research has been performed in cells and animals rather than human clinical trials.
There is currently no established clinical dosing protocol for injectable MGF in humans.
Bottom line:
The biology behind MGF and muscle repair is supported by research, but the dosing schedules used in peptide communities have not been validated in controlled human trials.
The biology behind MGF and muscle repair is supported by research, but the dosing schedules used in peptide communities have not been validated in controlled human trials.
Monitoring During Use
Recovery or soreness changes being observed
Training-performance changes
Injection-site tolerance
Localized swelling or unexpected tissue changes
Glucose-related symptoms when studying compounds connected to the broader IGF pathway
Benefits
Supports local muscle repair signaling
May enhance recovery after training
Associated with satellite cell activation
Useful in shorter recovery-focused protocols
Potential Side Effects
Injection site irritation
Mild soreness or swelling
Very limited human safety data
Combination & Stacking Considerations
MGF / IGF-Related Signaling → Consider Pathway Overlap → Avoid Assuming More = Better
Commonly Discussed Combinations
MGF + BPC-157: Discussed in recovery-focused communities, but no controlled human combination studies exist.
MGF + IGF-1 LR3: Creates additional IGF/growth-pathway exposure and should be viewed as a higher-overlap combination rather than a validated growth stack.
MGF vs PEG-MGF: These are usually discussed as different research approaches rather than compounds that must be combined.
What to Avoid
Treating community stacking practices as clinically established protocols.
Layering several IGF-related or GH-pathway compounds without recognizing pathway overlap.
Assuming evidence for endogenous MGF biology proves the safety or effectiveness of an injected MGF combination.
Evidence level:
No controlled human studies have established MGF stacking protocols. Evidence for one component of a combination should not be treated as evidence for the combination itself.
No controlled human studies have established MGF stacking protocols. Evidence for one component of a combination should not be treated as evidence for the combination itself.
Important Notes
MGF is commonly associated with the IGF-1Ec splice variant and muscle-response signaling after mechanical stress.
Human studies demonstrate changes in endogenous MGF/IGF-1Ec expression after exercise and muscle loading.
Those human expression studies are not the same as trials of injected synthetic MGF peptide.
Human dosing, pharmacokinetics, injection timing, cycle length, and long-term safety of synthetic MGF have not been established.
Localized-growth claims and post-workout injection protocols come largely from theory, preclinical work, and community practice.
Important Disclaimer
Synthetic MGF is an investigational research compound and is not FDA-approved for therapeutic use. Human studies of endogenous IGF-1Ec/MGF expression do not establish the safety, dosing, effectiveness, or long-term risks of injectable synthetic MGF protocols. This content is for educational purposes only.
Research & References
Primary Research
- Matheny RW Jr, Nindl BC, Adamo ML. Minireview: Mechano-Growth Factor: A Putative Product of IGF-I Gene Expression Involved in Tissue Repair and Regeneration. Endocrinology. 2010.
- Kandalla PK, Goldspink G, Butler-Browne G, Mouly V. Mechano Growth Factor E Peptide (MGF-E), Derived From an Isoform of IGF-1, Activates Human Muscle Progenitor Cells and Induces an Increase in Their Fusion Potential at Different Ages. Mechanisms of Ageing and Development. 2011.
- Goldspink G, Yang SY. Effects of Activity on Growth Factor Expression. International Journal of Sport Nutrition and Exercise Metabolism. 2001.
- Zabłocka B, Goldspink PH, Goldspink G, Górecki DC. Mechano-Growth Factor: An Important Cog or a Loose Screw in the Repair Machinery? Frontiers in Endocrinology. 2012.
Comments
Post a Comment